openPR Logo
Press release

Pharmacovigilance Market Share Growth Size Trends Report | Key Players: Accenture, Tata Consultancy Services, Cognizant, IQVIA, Coté Orphan, a QuintilesIMS company, PAREXEL

03-04-2019 09:14 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc

U.S. Pharmacovigilance Market, By Clinical Trial Phase, 2013 ? 2024 (USD Billion)

U.S. Pharmacovigilance Market, By Clinical Trial Phase, 2013 ? 2024 (USD Billion)

Increasing acceptance and adoption of outsourcing services by healthcare companies will stimulate pharmacovigilance (PV) market growth in forthcoming years. Outsourcing eliminates the risk of business overhead costs as well as deployment of a pharmacovigilance resources. Outsourcing strategy increases the cost-effectiveness and efficiency by relieving resource pressure on firms. Positively shifting trends in PV outsourcing owing to increasing benefits will accelerate pharmacovigilance business growth in the coming years.

Rising number of adverse drug reactions (ADRs) will contribute to significant increase in the market size over the forecast period. According to National Centre for Biotechnology Information (NCBI), number of fatalities due to ADRs increased more than two-fold in 2014. This further led to increase in hospitalizations. Similarly, according to data by Clinics, 2018, there was 10% increase in ADR rate in Brazil per medication introduced during hospitalization. Such escalating number of ADRs that require continuous pharmacovigilance will render lucrative growth opportunity for pharmacovigilance market to facilitate effective surveillance of ADRs.

Accelerating demand for personalized medicines will impel momentous industry growth in the foreseeable future. Innovations in personalized medicine will offer growth potential to the market in ways to develop and quantitate risks and benefits of personalized medicines. Increasing advancement in targeted drugs such as new product development will further propel demand for pharmacovigilance services in the coming years.

Request for a sample of this research report @

Dearth of skilled healthcare professionals needed to analyse data and implement solutions can restrict market growth. Moreover, increased risk for data security that can be misused by the pharmacovigilance personnel can hamper business growth over the coming years.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

 Accenture
 Tata Consultancy Services
 Cognizant
 IQVIA, Coté Orphan, a QuintilesIMS company

Phase IV pharmacovigilance segment accounted for the largest segmental share of 75.2% in 2017. Pharmacovigilance is vital as safety surveillance after the drug is sold to patients. It detects and reports any ADRs and harmful effects that may result into discontinuation of drugs or may be limited for use. Phase IV pharmacovigilance may negatively affect company’s financial and business performance. Thus, increasing number of pharmaceutical companies along with rising number of medicines will positively impact market growth, thereby boosting segmental share.

Preclinical trial pharmacovigilance segment will grow at 10.2% CAGR over the forecast period. Fast growth is attributable to accelerating number of new drug developments by pharma and biotech companies across the globe. Preclinical trial forms the foremost and crucial part of drug assessment and drug development. Thus, increasing demand for targeted therapies owing to rising number of diseases will boost segmental share in upcoming period.

Browse Full Report Details @

Outsourcing pharmacovigilance segment held largest revenue of USD 2,165.0 million in 2017. Enhanced cost-effectivity and better monitoring of drug safety will drive the outsourcing pharmacovigilance segment share in foreseeable years. Handling of large data volume coupled with regulatory compliance further attributes to increasing preference for pharmacovigilance outsourcing. For instance, many small pharmaceutical companies outsource some of its drug safety work to a third-party while 82% of medium sized and 45% large size companies outsource pharmacovigilance, that shows shifting customer preference. Above factors will highly impact outsourcing pharmacovigilance market growth.

U.S. market accounted for 86.9% share of North American market in 2017. Sophisticated healthcare infrastructure coupled with stringent pharmacovigilance guidelines will augment regional growth over the projected period. U.S. FDA mandates the pharmaceutical companies to conduct post-marketing surveillance and report ADRs within stipulated time-frames. In addition, increasing funding for clinical trials will favor U.S. pharmacovigilance industry growth.

India market will grow at a rapid pace exceeding USD 520 million by 2024. Strict regulations for reporting adverse drug reactions coupled with rising demand for pharmacovigilance outsourcing across the nation will foster the market growth. Lower labour cost as well as attractive market place for conducting clinical trials will positively impact the global market size.

Make an inquiry for purchasing this report @

Pharmacovigilance industry witnessed remarkable developments owing to rising number of adverse drug reactions, side effects coupled with potential threats to the consumers. Pharmacovigilance was implemented in developed nations earlier in 1970s, including U.S. and UK following numerous consumer health protection acts. Increasing number of pharmaceutical companies, as well as global harmonization practices will further assist advancements in the market. Furthermore, emergence of personalized medicines and rising number of ADRs should drive pharmacovigilance industry size in the foreseeable future.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance Market Share Growth Size Trends Report | Key Players: Accenture, Tata Consultancy Services, Cognizant, IQVIA, Coté Orphan, a QuintilesIMS company, PAREXEL here

News-ID: 1630927 • Views: 609

More Releases from Global Market Insights, Inc

Refractories Market 2020 by top key players Saint-Gobain, Morgan Advanced Materi …
Global Refractories Market size was estimated at USD 30 billion in 2018 and is projected to surpass USD 41 billion by the year 2025. Refractories market is classified into monolithic, brick & shapes and others. Other refractories products is expected to gain close to 3% by 2025. Other refractory products include ceramic fibers and refractories raw materials used for manufacturing refractories inhouse. Ceramic fibers are lightweight, has high temperature stability and
Offshore Crane Market Trends 2020 By Industry Players Liebherr Group, National O …
The size of the overall Offshore Crane Market was recorded at USD 2.5 billion in the year 2018 and is now projected to surpass around USD 5 billion by 2026. The ongoing exploration of new offshore oil & gas fields will surge the demand for offshore cranes. The growing demand for maintenance & repair of oil & gas extraction systems will drive the offshore crane market growth. The equipment is primarily
Assisted Reproductive Technology Market Top Players | Cooper Surgical Inc., Cook …
Assisted Reproductive Technology Market will reach over USD 32.5 billion by 2024; as per a new research report. Increasing number of people suffering from infertility issues coupled with rising awareness about assisted reproductive technology (ART) will drive ART market over the forecast timeframe. Furthermore, changing social factors and rising disposable income should positively impact industry expansion. Procedures such as in-vitro fertilization are offered at low cost in developing countries such as
What's driving the Lithopone Market growth? | Leading Key Players Titanos, Langf …
A report by DecResearch estimates that the lithopone market size will be valued at over $235 million by 2025. Rapid global urbanization has given rise to a thriving construction industry which is a significant contributor to the lithopone market growth. The strong reducing power and chemically inert nature of lithopone has led to its extensive application across numerous industries including paints & coatings, paper& pulp, rubber, leather, plastics and linoleum

All 5 Releases